Lamotrigine/Clonazepam

拉莫三嗪/氯硝西泮

Report date: 2022/02/14 16:04:15

Base Information

Drug NameLamotrigine/Clonazepam
Drug Alias NameCionamat
ClassificationSmall molecules
Mechanisms of ActionGamma-aminobutyric acid A receptor agonists
TargetsSodium channel alpha subunitGamma-aminobutyric acid A receptor
Therapy Area/IndicationsBipolar DisorderRestless Legs SyndromeEpilepsy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes LamotrigineClonazepam
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesTevaInterlab Pharmaceutical
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsBipolar DisorderRestless Legs SyndromeEpilepsy
Inactive IndicationsN/A

Other Information

ATC CodeN03A
Related LinksN/A